💨 Abstract
In the second quarter, Plus Therapeutics, Inc. reported a profit of $5.2 million despite a net loss of 1 cent per share. The Houston-based cell therapy developer generated $1.4 million in revenue for the period.
Courtesy: WTOP Staff
Suggested
EE.UU. y Europa siguen haciendo negocios por miles de millones de dólares con Rusia a pesar de años de guerra -
Drive Shack: Q2 Earnings Snapshot -
Delaware ex-Gov. Mike Castle, who championed 50 State Quarters Program while in Congress, dies at 86 -
Maye and McCarthy show progress in Patriots-Vikings joint practices -
Louisiana sues Roblox alleging the popular gaming site fails to protect children -
Oramed: Q2 Earnings Snapshot -
Carbon Streaming: Q2 Earnings Snapshot -
Barbadillo, la prisión sin barrotes para expresidentes que se ha convertido en símbolo de la crisis política en Perú -
Ziopharm: Q2 Earnings Snapshot -
How Rattler and Shough handled live pass rush will be another data point in Saints’ QB competition -